AKT1 and Parkinson disease: can improve the Unified Parkinson's Disease Rating Scale (UPDRS) score of patients with Parkinson's disease [3], increase the expression of neurotrophic factors in the brain of PD model rats [4], and enhance the expression of phosphoinositide 3-kinase (PI3K) and protein kinase B (AKT) [5, 6].